A detailed history of Advisor Group Holdings, Inc. transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 5,720 shares of SGMO stock, worth $14,128. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,720
Previous 5,920 3.38%
Holding current value
$14,128
Previous $2,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$0.32 - $1.1 $64 - $220
-200 Reduced 3.38%
5,720 $4,000
Q2 2024

Aug 13, 2024

SELL
$0.36 - $0.65 $1,306 - $2,359
-3,630 Reduced 38.01%
5,920 $2,000
Q1 2024

May 10, 2024

SELL
$0.42 - $1.38 $165 - $543
-394 Reduced 3.96%
9,550 $6,000
Q4 2023

Feb 12, 2024

SELL
$0.3 - $0.63 $769 - $1,616
-2,566 Reduced 20.51%
9,944 $5,000
Q3 2023

Nov 13, 2023

SELL
$0.58 - $1.47 $2,430 - $6,159
-4,190 Reduced 25.09%
12,510 $7,000
Q2 2023

Aug 10, 2023

SELL
$1.11 - $1.74 $2,800 - $4,390
-2,523 Reduced 13.12%
16,700 $21,000
Q1 2023

May 12, 2023

BUY
$1.66 - $3.67 $549 - $1,214
331 Added 1.75%
19,223 $33,000
Q4 2022

Feb 10, 2023

SELL
$2.77 - $5.07 $6,808 - $12,462
-2,458 Reduced 11.51%
18,892 $59,000
Q2 2022

Aug 10, 2022

SELL
$3.28 - $6.21 $8,354 - $15,816
-2,547 Reduced 10.66%
21,350 $89,000
Q1 2022

May 04, 2022

BUY
$5.23 - $7.82 $10,046 - $15,022
1,921 Added 8.74%
23,897 $192,000
Q3 2021

Nov 05, 2021

BUY
$9.01 - $12.01 $14,992 - $19,984
1,664 Added 8.19%
21,976 $199,000
Q2 2021

Aug 02, 2021

SELL
$10.17 - $12.64 $80,139 - $99,603
-7,880 Reduced 27.95%
20,312 $244,000
Q1 2021

May 13, 2021

BUY
$10.88 - $17.05 $125,903 - $197,302
11,572 Added 69.63%
28,192 $353,000
Q4 2020

Feb 10, 2021

SELL
$9.23 - $18.18 $8,168 - $16,089
-885 Reduced 5.06%
16,620 $257,000
Q3 2020

Nov 12, 2020

SELL
$9.38 - $12.48 $3,020 - $4,018
-322 Reduced 1.81%
17,505 $166,000
Q2 2020

Aug 14, 2020

SELL
$6.21 - $11.83 $5,011 - $9,546
-807 Reduced 4.33%
17,827 $161,000
Q1 2020

May 18, 2020

BUY
$5.05 - $8.85 $94,101 - $164,910
18,634 New
18,634 $119,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $387M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.